These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37550006)

  • 1. Infant mortality rates and pneumococcal vaccines: a time-series trend analysis in 194 countries, 1950-2020.
    Sanchez CA; Rivera-Lozada O; Lozada-Urbano M; Best P
    BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37550006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact of pneumococcal conjugate vaccines for children on adult pneumococcal pneumonia in Japan: Two multicenter observational studies from 2011 to 2020.
    Maeda H; Gopal Dhoubhadel B; Sando E; Suzuki M; Furumoto A; Asoh N; Yaegashi M; Aoshima M; Ishida M; Hamaguchi S; Otsuka Y; Morimoto K
    Vaccine; 2022 Sep; 40(37):5504-5512. PubMed ID: 35963821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.
    Palmborg A; Skovdal M; Molden T; Åhman H; Chen L; Banefelt J
    PLoS One; 2023; 18(6):e0287378. PubMed ID: 37363884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
    Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
    Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Pneumococcal Disease burden and PCV coverage in children under five in Southeast Asia: implications for India.
    Kolhapure S; Yewale V; Agrawal A; Krishnappa P; Soumahoro L
    J Infect Dev Ctries; 2021 Jun; 15(6):749-760. PubMed ID: 34242182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
    Agudelo CI; Castañeda-Orjuela C; Brandileone MCC; Echániz-Aviles G; Almeida SCG; Carnalla-Barajas MN; Regueira M; Fossati S; Alarcón P; Araya P; Duarte C; Sánchez J; Novas M; Toraño-Peraza G; Rodríguez-Ortega M; Chamorro-Cortesi G; Kawabata A; García-Gabarrot G; Camou T; Spadola E; Payares D; Andrade AL; Di Fabio JL; Castañeda E;
    Lancet Infect Dis; 2021 Mar; 21(3):405-417. PubMed ID: 32986996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Jimbo Sotomayor R; Toscano CM; Sánchez Choez X; Vilema Ortíz M; Rivas Condo J; Ghisays G; Haneuse S; Weinberger DM; McGee G; de Oliveira LH
    Vaccine; 2020 Oct; 38(45):7033-7039. PubMed ID: 32981782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declines in Pneumonia Mortality Following the Introduction of Pneumococcal Conjugate Vaccines in Latin American and Caribbean Countries.
    de Oliveira LH; Shioda K; Valenzuela MT; Janusz CB; Rearte A; Sbarra AN; Warren JL; Toscano CM; Weinberger DM;
    Clin Infect Dis; 2021 Jul; 73(2):306-313. PubMed ID: 32448889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
    Wang J; Wu QS; Lu J; Ni YH; Zhou F
    Vaccine; 2021 Oct; 39(42):6189-6194. PubMed ID: 34538698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016).
    Moreira M; Castro O; Palmieri M; Efklidou S; Castagna S; Hoet B
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-12. PubMed ID: 27996380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.
    Cohen R; Cohen JF; Chalumeau M; Levy C
    Expert Rev Vaccines; 2017 Jun; 16(6):625-640. PubMed ID: 28409537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.
    Wasserman M; Chapman R; Lapidot R; Sutton K; Dillon-Murphy D; Patel S; Chilson E; Snow V; Farkouh R; Pelton S
    Emerg Infect Dis; 2021; 27(6):1627-1636. PubMed ID: 34013855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.